KORU MEDICAL SYSTEMS, INC. (KRMD) Operating Margin
- Operating margin · 12 months: Value -3.66%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -3.66% | Operating income / revenue. Period ending 2026-06-30. $-1.65M ÷ $45.11M × 100 ≈ -3.66% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -1.65M USD | Operating Income (Loss) |
| Revenue | 45.11M USD | |
| Cost of products and services | 16.95M USD | Cost of Goods and Services Sold |
| Research and development | 4.46M USD | Research and Development Expense |
| Selling, general and administration | 24.56M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-1.65M | $45.11M | $16.95M | $4.46M | $24.56M | -3.66% |
| 2026-03-31 | $-2.59M | $43.26M | $16.47M | $4.59M | $24.00M | -5.99% |
| 2025-12-31 | $-2.97M | $41.13M | $15.52M | $4.39M | $23.38M | -7.23% |
| 2025-09-30 | $-4.01M | $39.07M | $14.72M | $4.36M | $23.16M | -10.28% |
| 2025-06-30 | $-4.85M | $36.85M | $13.58M | $4.96M | $22.30M | -13.16% |
| 2025-03-31 | $-5.73M | $35.08M | $12.81M | $4.90M | $22.23M | -16.33% |
| 2024-12-31 | $-6.45M | $33.65M | $12.31M | $5.26M | $21.63M | -19.16% |
| 2024-09-30 | $-7.05M | $31.99M | $11.89M | $5.43M | $20.82M | -22.05% |
| 2024-06-30 | $-7.14M | $30.82M | $11.56M | $5.19M | $20.31M | -23.18% |
| 2024-03-31 | $-9.17M | $29.32M | $11.66M | $5.65M | $20.30M | -31.29% |
| 2023-12-31 | $-10.27M | $28.52M | $11.81M | $5.74M | $20.37M | -36.01% |
| 2023-09-30 | $-10.58M | $28.68M | $12.22M | $6.10M | $20.11M | -36.91% |
| 2023-06-30 | $-10.32M | $29.43M | $13.00M | $5.67M | $20.31M | -35.07% |
| 2023-03-31 | $-10.71M | $29.04M | $13.15M | $5.37M | $20.54M | -36.88% |
| 2022-12-31 | $-10.78M | $27.90M | $12.53M | $4.96M | $20.61M | -38.65% |
| 2022-09-30 | $-10.38M | $27.04M | $11.92M | $4.26M | $20.73M | -38.39% |
| 2022-06-30 | $-10.18M | $25.32M | $11.03M | $4.20M | $19.80M | -40.18% |
| 2022-03-31 | $-7.94M | $24.30M | $10.14M | $3.29M | $18.36M | -32.68% |
| 2021-12-31 | $-7.03M | $23.49M | $9.72M | $2.47M | $17.86M | -29.93% |
| 2021-09-30 | $-6.08M | $21.06M | $8.82M | $1.88M | $15.97M | -28.88% |
| 2021-06-30 | $-4.40M | $21.10M | $8.42M | $1.47M | $15.14M | -20.86% |
| 2021-03-31 | $-4.05M | $23.28M | $8.90M | $1.38M | $14.16M | -17.40% |
| 2020-12-31 | $-1.25M | $24.18M | $9.24M | $1.30M | $12.03M | -5.19% |
| 2020-09-30 | $-250.00K | $26.34M | $9.76M | $1.23M | $11.84M | -0.95% |
| 2020-06-30 | $215.66K | $26.88M | $9.85M | $1.01M | $11.20M | 0.80% |
| 2020-03-31 | $1.28M | $24.52M | $8.92M | $894.54K | $10.05M | 5.24% |
| 2019-12-31 | $585.68K | $23.16M | $8.31M | $740.48K | $9.77M | 2.53% |
| 2019-09-30 | $309.03K | (m) | $7.59M | $530.84K | $10.56M | (m) |
| 2019-06-30 | $-32.77K | (m) | $7.01M | $487.51K | $11.35M | (m) |
| 2019-03-31 | $548.37K | (m) | $6.90M | $333.24K | $10.19M | (m) |
| 2018-12-31 | $1.16M | (m) | $6.54M | $241.12K | $9.10M | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-02-28 | $-736.25K | $12.29M | (m) | $237.49K | $7.77M | -5.99% |
| 2016-11-30 | $-137.78K | $12.64M | (m) | $246.84K | $7.52M | -1.09% |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-08-31 | $264.91K | $12.59M | (m) | $239.26K | $7.18M | 2.10% |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-05-31 | $890.65K | $12.61M | (m) | $210.28K | $6.64M | 7.06% |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-02-29 | $1.18M | $12.25M | (m) | $207.28K | $5.94M | 9.65% |
| 2015-11-30 | $1.17M | $12.39M | (m) | $205.39K | $5.92M | 9.45% |
| 2015-08-31 | $1.02M | $11.90M | (m) | $270.71K | $5.48M | 8.53% |
| 2015-05-31 | $827.43K | $11.24M | (m) | $390.42K | $5.17M | 7.36% |
| 2015-02-28 | $1.15M | $11.24M | (m) | $468.15K | $4.79M | 10.20% |
| 2014-11-30 | $1.20M | $10.43M | (m) | $493.12K | $4.40M | 11.51% |
| 2014-08-31 | $1.31M | $9.96M | (m) | $427.10K | $4.12M | 13.13% |
| 2014-05-31 | $1.12M | $9.46M | (m) | $311.79K | $3.99M | 11.88% |
| 2014-02-28 | $1.01M | $8.70M | (m) | $218.15K | $3.85M | 11.58% |
| 2013-11-30 | $788.18K | $8.06M | (m) | $167.86K | $3.78M | 9.78% |
| 2013-08-31 | $634.96K | $7.95M | (m) | $153.06K | $3.91M | 7.98% |
| 2013-05-31 | $1.04M | $7.90M | (m) | $146.96K | $3.61M | 13.19% |
| 2013-02-28 | $1.06M | $7.76M | (m) | $147.58K | $3.54M | 13.68% |
| 2012-11-30 | $1.33M | $7.80M | (m) | $152.48K | $3.44M | 17.02% |
| 2012-08-31 | $1.47M | $7.23M | (m) | $143.02K | $2.96M | 20.28% |
| 2012-05-31 | $1.10M | $6.64M | (m) | $115.98K | $2.95M | 16.61% |
| 2012-02-29 | $1.29M | $6.39M | (m) | $90.33K | $2.66M | 20.17% |
| 2011-11-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-08-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-05-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-02-28 | $1.19M | $4.92M | (m) | $35.52K | $1.97M | 24.28% |
| 2010-11-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-08-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |